Quest Diagnostics (NYSE:DGX) Target Raised by Wells Fargo & Company to $150.00

StockMarketDaily.co reports: Quest Diagnostics stock has undergone multiple analysts rating changes in the recent past.  Quest Diagnostics stock Target Raised by   Wells Fargo & Company on 10/26/2021. In a note to investors, the firm issued a new target price of $150.00. The analysts previously had $140.00 target price.

View More Quest Diagnostics (NYSE:DGX) Target Raised by Wells Fargo & Company to $150.00